Calgranulin B and KL-6 in Bronchoalveolar Lavage of Patients with IPF and NSIP.


Journal

Inflammation
ISSN: 1573-2576
Titre abrégé: Inflammation
Pays: United States
ID NLM: 7600105

Informations de publication

Date de publication:
Apr 2019
Historique:
pubmed: 27 1 2019
medline: 3 8 2019
entrez: 26 1 2019
Statut: ppublish

Résumé

Idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP) are the most frequent idiopathic interstitial pneumonias. The aim of this study was to evaluate concentrations of calgranulin B and Krebs von den Lungen 6 (KL-6) in bronchoalveolar lavage (BAL) fluid of patients with IPF and idiopathic NSIP (i-NSIP) with fibrotic pattern. Thirty patients with IPF (68.73 ± 8.63 years), 30 with i-NSIP (68.33 ± 7.45 years), and healthy controls were included in the study. Calgranulin B and KL-6 both proved to be significantly higher in BAL of IPF and i-NSIP patients than in healthy controls (p < 0.05). Calgranulin B showed several significant correlations with functional parameters (oxygen demand at rest, 6-min walking test (6MWT), and PFTs); KL-6 was correlated with oxygen demand at rest and during 6MWT. Patients with higher concentrations of both biomarkers (> 75th percentile) had more advanced disease with lower values of FEV1%, FVC%, RV%, TLC%, DLCO% of predicted, distance walked in 6MWT, and BAL neutrophil percentage. Calgranulin B and KL-6 in BAL proved to be reliable biomarkers of IPF and i-NSIP and to have prognostic meaning, discriminating severe and advanced patients. The combination of the two biomarkers can facilitate the stratification of severity.

Identifiants

pubmed: 30680696
doi: 10.1007/s10753-018-00955-2
pii: 10.1007/s10753-018-00955-2
doi:

Substances chimiques

Biomarkers 0
Calgranulin B 0
MUC1 protein, human 0
Mucin-1 0

Types de publication

Journal Article

Langues

eng

Pagination

463-470

Commentaires et corrections

Type : CommentIn

Références

Eur Respir J. 2005 Jul;26(1):153-61
pubmed: 15994402
Respirology. 2006 Mar;11(2):164-8
pubmed: 16548901
Inflammation. 2008 Oct;31(5):351-4
pubmed: 18784990
Respir Med. 2010 Jan;104(1):127-33
pubmed: 19811899
Inflammation. 2011 Apr;34(2):85-91
pubmed: 20422274
Clin Exp Immunol. 2010 Aug;161(2):342-7
pubmed: 20550547
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
pubmed: 21471066
Sarcoidosis Vasc Diffuse Lung Dis. 2011 Jul;28(1):27-33
pubmed: 21796888
Respir Med. 2012 Apr;106(4):571-80
pubmed: 22209187
Am J Respir Crit Care Med. 2012 May 1;185(9):1004-14
pubmed: 22550210
Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48
pubmed: 24032382
Respir Med. 2014 Jul;108(7):1031-9
pubmed: 24835074
Eur Respir J. 2014 Dec;44(6):1428-46
pubmed: 25359355
Eur Respir J. 2015 Mar;45(3):746-55
pubmed: 25537566
Curr Top Med Chem. 2016;16(14):1587-98
pubmed: 26420365
Zhonghua Jie He He Hu Xi Za Zhi. 2016 Feb;39(2):93-7
pubmed: 26879611
Oncogene. 2016 Nov 3;35(44):5735-5745
pubmed: 27086923
Orphanet J Rare Dis. 2016 Apr 23;11:48
pubmed: 27108412
Dis Markers. 2016;2016:4759040
pubmed: 27293304
Respir Investig. 2017 Jan;55(1):16-23
pubmed: 28012488
Am J Surg Pathol. 1994 Feb;18(2):136-47
pubmed: 8291652

Auteurs

David Bennett (D)

Respiratory Diseases and Lung Transplantation Unit, AOUS - Department of Medical, Surgical and Neurological Sciences, University of Siena, Viale Bracci, 16 -, 53100, Siena, Italy. david.btt@gmail.com.

Martina Salvini (M)

Respiratory Diseases and Lung Transplantation Unit, AOUS - Department of Medical, Surgical and Neurological Sciences, University of Siena, Viale Bracci, 16 -, 53100, Siena, Italy.

Annalisa Fui (A)

Respiratory Diseases and Lung Transplantation Unit, AOUS - Department of Medical, Surgical and Neurological Sciences, University of Siena, Viale Bracci, 16 -, 53100, Siena, Italy.

Giuseppe Cillis (G)

Respiratory Diseases and Lung Transplantation Unit, AOUS - Department of Medical, Surgical and Neurological Sciences, University of Siena, Viale Bracci, 16 -, 53100, Siena, Italy.

Paolo Cameli (P)

Respiratory Diseases and Lung Transplantation Unit, AOUS - Department of Medical, Surgical and Neurological Sciences, University of Siena, Viale Bracci, 16 -, 53100, Siena, Italy.

Maria Antonietta Mazzei (MA)

Diagnostic Imaging Unit, AOUS - Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.

Antonella Fossi (A)

Respiratory Diseases and Lung Transplantation Unit, AOUS - Department of Medical, Surgical and Neurological Sciences, University of Siena, Viale Bracci, 16 -, 53100, Siena, Italy.

Rosa Metella Refini (RM)

Respiratory Diseases and Lung Transplantation Unit, AOUS - Department of Medical, Surgical and Neurological Sciences, University of Siena, Viale Bracci, 16 -, 53100, Siena, Italy.

Paola Rottoli (P)

Respiratory Diseases and Lung Transplantation Unit, AOUS - Department of Medical, Surgical and Neurological Sciences, University of Siena, Viale Bracci, 16 -, 53100, Siena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH